(EMAILWIRE.COM, April 08, 2019 ) In 2016, Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US) held the leading position in the global atherectomy devices market. In the past three years, these companies adopted product launches, strategic acquisitions, mergers, agreements, collaborations, and expansions as their key business strategies to ensure market dominance. Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US) are some of the other major players in this market.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=133112140

Stakeholders
-Original equipment manufacturers (OEMs)
-Product sales and distribution companies
-Healthcare service providers (hospitals and surgical centers)
-Non-government organizations
-Government regulatory authorities
-Research laboratories and academic institutes
-Clinical research organizations (CROs)
-Research and development companies
-Market research and consulting firms

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%.

The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).

Speak to Our Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=133112140

Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.